Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab for primary Sjögren disease
2005-004740-31Phase 2Completed
- Sponsor
- University of Copenhagen
- Start
- Nov 2005
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, single-arm trial of rituximab in primary Sjögren's syndrome, sponsored by University of Copenhagen. Primary endpoints: Subjective oral dryness, Subjective ocular dryness and 3 more. Started Nov 2005; status: completed.
02
Drugs
rituximab
03
Conditions
primary Sjögren's syndrome
Beyond the preview
Go deeper on 2005-004740-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004740-31.